Prostate cancer cells may then selectively rely on PFKFB4 for managing ROS accumulation, since treatment with a ROS scavenger rescued the viability defect in the PFKFB4-knockdown prostate cancer cells. The gene discussed is PFKFB4; the disease is prostate carcinoma.